PETALING JAYA: Kenanga Research says Nova Wellness Group Bhd
’s slower-than-expected production ramp up at its new plant will likely drag top line contribution and impact margins due to weaker-than-anticipated economies of scale.
As such, the research house is cutting its financial year 2025 (FY25) and FY26 net profit by 21% and 31% respectively and reducing its target price by 20% to RM0.41, from RM0.51.
